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Abstract
The cellular distribution of inositol 1,4,5-trisphosphate receptors was examined in rodent maxillary incisor teeth. In situ
hybridization studies with a transmembrane probe of type I inositol 1,4,5-trisphosphate receptor indicated that this
receptorrchannel was highly expressed in odontoblast cells of incisor teeth. In contrast, very low labeling was observed in
dental pulp. Northern analysis showed a message size of approximately 9.5 kilobases for this receptor, and demonstrated
that type III inositol 1,4,5-trisphosphate receptor was expressed in incisor teeth. Immunocytochemical studies confirmed that
types I and III inositol 1,4,5-trisphosphate receptors were both highly expressed in odontoblasts while very low expression
was detected in dental pulp. Finally, antibodies that recognized alpha subunits of the G class of GTP binding proteins alsoq
stained odontoblasts. These results indicate that receptor-mediated regulation of calcium release through inositol 1,4,5-tris-
phosphate receptors may occur in odontoblasts of rat incisor teeth. These findings also suggest that inositol 1,4,5-tris-
phosphate receptorrchannels regulate calcium flux in odontoblasts during mineralization of dentin, or in growth and
differentiation of incisor tissue. q 1997 Elsevier Science B.V.
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1. Introduction
Many cellular responses are mediated by the sec-
ond messengers D-myo-inositol 1,4,5-trisphosphate
 .  . w xIP and 1,2-diacylglycerol DAG 1 . The subse-3
quent binding of IP to a tetrameric receptorrchannel3
regulates calcium release into the cytoplasm from
w xnon-mitochondrial internal membrane stores 1 . IP3
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receptors exhibit heterogeneity at the genetic level
since these receptors are encoded by a family of at
w xleast five genes 2–6 . The complete DNA sequences
of three IP receptor subtypes, named I, II, and III,3
have been reported. These genes exhibit greater than
w x60% sequence identity 2–6 . Partial DNA sequences
from two other IP receptor subtypes have been3
reported, and both share extensive sequence identity
w xwith type II receptor 4,7 . Further IP receptor het-3
erogeneity arises from alternative splicing since type
w xI IP receptor is spliced at two distinct sites 5,8 .3
Finally, IP receptor heterogeneity occurs from sub-3
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unit mixing since IP receptors can assemble into3
functional heterotetrameric complexes of specific re-
w xceptor subtypes 9–11 . Type I, II, and III IP recep-3
w xtors possess differing binding affinities for IP 12 ,3
w xare differentially regulated by proteolysis 13 , and
may be differentially regulated by phosphorylation
w x8,14 . This heterogeneity suggests that IP receptors3
are functionally diverse, and a variety of roles have
been suggested for IP receptors that include the3
w xregulation of cellular secretion 1,15–17 .
Intracellular calcium flux is critical for the forma-
tion of calcified connective tissue. During mineraliza-
tion of dentin, an organic matrix is formed in which
inorganic calcium phosphate is deposited as mineral
w xcrystals of hydroxyapatite 18,19 . The initial dentin
crystallization step is presumed to occur within mem-
w xbrane-bound matrix vesicles 20,21 . These vesicles
are thought to induce mineralization by sequestering
calcium and phosphate ions that are initially bound to
polyanionic proteins. These proteins may transport
w xcalcium to the sites of dentin mineralization 21,22 .
In addition, these calcium salts may serve as nucle-
ation centers for further mineralization of the dentin
w xmatrix 21 .
Odontoblast cells of mammalian teeth are respon-
sible for dentin formation since these cells actively
transport calcium and proteinaceous components to-
w xward the site of mineral formation 18,20,21 . These
highly polarized secretory cells line the surface of
dentin where the predentin matrix is first deposited
w x18,21 . We recently observed high expression of IP3
receptors within the odontoblast layer of rat incisor
teeth. In this report, we characterize the expression of
type I and type III IP receptors and a phosphoinosi-3
 .tide-specific GTP binding protein G-protein within
rodent incisor teeth.
2. Materials and methods
2.1. Extraction of tissue and RNA extraction
Rat maxillary incisors were dissected from adult
Sprague-Dawley rats, and washed in modified KHE
buffer to remove all external tissue. Both olfactory
and olfactory bulb tissue from rats were removed and
w xfrozen at y808C as previously described 15 . For
histological studies, entire nasal structures from rats
were removed, frozen in isopentane at y408C, and
stored at y808C. Human cerebellar tissue served as a
positive control for in situ hybridization studies. This
tissue was obtained from the Mental Health Clinical
Research Center in Schizophrenia at the University of
Pennsylvania, and frozen in isopentane as described
above.
For RNA extraction, rat incisor teeth were frozen
in dry ice and ground with a mortar and pestle to a
fine powder. Total RNA from rat incisors and rat
olfactory tissue was prepared by acid–phenol extrac-
w x  .tion 23 or by TRIzol extraction GibcorBRL . Rat
olfactory and olfactory bulb RNA both served as
w xpositive controls for detection of IP receptor 15 .3
The integrity of RNA samples was determined by
formaldehyde–agarose gel electrophoresis before
Northern analysis.
2.2. Northern analysis
Northern analysis was carried out by electrophore-
w xsis in 1.2% formaldehyde–agarose gels 24 . RNA
was transferred to nylon membranes by capillary
action. Prehybridization and hybridization were car-
ried out at 42 or 458C in 50% formamide by standard
w xmeans 24 . Membranes were washed in 0.1% SDS to
a final wash stringency of 0.2=SSC at 60 or 658C.
A cDNA of type I IP receptor previously amplified3
from rat olfactory tissue was used for Northern analy-
 .sis clone pUP3, GenBank accession no. U38812 .
This DNA was amplified from a transmembrane do-
main sequence, and showed 100% sequence identity
w xto type I IP receptor from rat cerebellum 15 . Probe3
DNA was prepared by EcoRI digestion, separated by
agarose gel electrophoresis, purified by glass milk
 . w xBio 101 , and labeled with random primer 25 . A
PAGE-purified antisense oligonucleotide to a unique
sequence of type III IP receptor from rat was com-3
mercially synthesized. This sequence was 5X-CTGCT-
TGTTGTTGAGGCTGAGCATGGAAGAGATGCC-
CTCGGCCTCCTCC-3X, and corresponded to nu-
w xcleotides 6368–6416 6 . This oligomer is compli-
mentary to a cDNA sequence not found in type I or
w xtype II IP receptor 6 . In addition, this oligomer3
does not hybridize to type I IP receptor mRNA3
under the hybridization conditions used in this study
w x15 . This oligomer was end-labeled with deoxynu-
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cleotidyl transferase and 32P-dATP and hybridized as
described above.
2.3. In situ hybridization
The IP receptor cDNA from pUP3 was also used3
for in situ hybridization of rat incisor teeth. Plasmid
DNA was purified by alkaline lysis followed by
equilibrium centrifugation through a cesium chlo-
ride–ethidium bromide gradient, and linearized. Anti-
sense RNA transcripts were prepared by in vitro
transcription with T7 DNA-dependent RNA poly-
merase and 35S-UTP. Fresh-frozen sections of rat
olfactory tissue and adult human cerebellum were
sectioned on a Frigocut cryostat, and thaw mounted
q  .onto ProbeOn slides Fisher Scientific . Tissue was
fixed in 3% paraformaldehyde, washed, and acety-
lated in 0.25% acetic anhydride, again washed, and
dehydrated through a series of graded ethanols. Tis-
sue sections were then prehybridized and hybridized
w xin 50% formamide at 608C by standard means 26 .
Hybridization was as described above except with
10% dextran sulfate and radioactive probe. After
hybridization, sections were first washed in 2=
SSCr0.1% 2-mercaptoethanol, then washed in 2=
SSXC and 2=SSCr50% formamide, and then di-
w xgested with RNase A by standard means 26 . Final
wash stringency was 0.2=SSC at 608C. After dehy-
dration, slides were dipped in Kodak NTB-2 photo-
graphic emulsion diluted 1:1 with 0.05% Dreft deter-
gent, and exposed at 48C for 5–7 days. Tissue sec-
tions were developed, briefly stained with Nissl stain,
and observed. Sense transcripts were prepared by SP6
Fig. 1. Northern analysis of IP receptor expression in rat incisor3
 .teeth and rat olfactory tissues. A Northern analysis with trans-
membrane IP receptor probe, pUP3. Lane 1, 15 mg rat incisor3
RNA; Lane 2, 30 mg rat incisor RNA; lane 4, 15 mg rat olfactory
RNA; lane 5, 30 mg rat olfactory RNA; lane 7, 15 mg rat
 .olfactory bulb RNA. Numbers to the left of lane 1 =1000
 .correspond to molecular size markers. B Northern analysis with
antisense oligonucleotide of a unique sequence of type III IP3
receptor. Lane 1, 15 mg rat incisor RNA; lane 2, 30 mg rat
incisor RNA; Lane 3, 15 mg rat olfactory RNA; lane 4, 30 mg rat
olfactory RNA. Lanes 3 and 4 are positive control RNA from a
second blot that was hybridized under the same conditions used
for lanes 1 and 2.
DNA-dependent RNA polymerase transcription of
linearized DNA, and processed as above.
2.4. Immunocytochemistry
Antibodies prepared to synthetic peptides of the
C-termini of types I and III IP receptorrchannels are3
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w xsubtype-specific 9,13 . Antibody T210 was prepared
from a synthetic peptide of the 19 C-terminal amino
acids of mouse type I receptor, has been extensively
characterized, and is specific for type I IP receptor3
w x2,27 . Antibody CT-3 was also prepared from a
synthetic peptide of the 14 C-terminal amino acids of
rat type III receptor, is well characterized, and is
w xspecific for type III IP receptor 9,28 . Antibody3
0946 recognizes the a subunit of two members of the
G class of G-proteins. This antiserum was directedq
against the synthetic decapeptide QLNLKEYNLV
w x29 , a sequence common to both Ga and Gaq 11
subunits of heterotrimeric G-proteins. Tissue sections
were fixed for 1 h in 10% formaldehyde in 0.1 M
PBS at pH 7.2, washed, and incubated with 0.25%
H O in 0.1 M PBS. Non-specific binding was2 2
blocked with 4% horse serumr0.1 M Tris before
addition of both primary and secondary antibodies.
Tissue was exposed to diluted primary antibody
overnight at 48C type I IP receptor antibody, 1:2503
dilution; type III IP receptor antibody, 1:500 dilu-3
.tion; Ga rGa antibody, 1:300 dilution , andq 11
washed. Specifically bound primary antibody was
localized with a biotinylated anti-rabbit IgG sec-
ondary antibody, according to the manufacturer’s in-
 . X Xstructions Vectastain, Vector Laboratories . 3 3 -Di-
aminobenzidine tetrahydrochloriderH O was the2 2
substrate for the chromogenic reaction. Immunocyto-
chemical controls included omission of primary anti-
body. For antibody T210 and antibody 0946, primary
antibody was preabsorbed overnight at 48C with a
 .20–25-fold wtrwt excess of peptide antigen, and
centrifuged. Tissue was then incubated with each
supernatant and processed for immunocytochemistry
as described above.
3. Results
3.1. Northern analysis of IP receptors with rodent3
incisor tissue
Clone pUP3 encoded a conserved transmembrane
domain of type I IP receptor, and exhibited 77 and3
79% sequence identity with types II and III receptors,
w xrespectively 15 . This cDNA was used for Northern
analysis to determine the overall expression of IP3
receptors within rat incisor tissue. Fig. 1A shows the
results of these experiments. A single message that
corresponded to the expected size of approximately
 .9.5 kilobases kb was observed in RNA from in-
cisors, olfactory tissue, and olfactory bulb tissue.
Based on optical absorbance of total RNA, IP recep-3
tor expression was greater in incisor teeth when
compared to either olfactory or olfactory bulb RNA.
Next, an antisense oligonucleotide that represented
w xa unique sequence of type III IP receptor 6,15 was3
used to identify expression of this IP receptor sub-3
type in rat incisor teeth. Fig. 1B shows that this
oligomer hybridized to a single message size of
approx. 9.5 kb in both rat incisor RNA and in rat
olfactory RNA. These results demonstrate that type
III IP receptor was expressed in rat incisors, and this3
RNA was similar in size to that reported in other
w xtissue 6 .
 .Fig. 2. Histochemical studies of IP receptor and Ga rGa expression in rat incisor and human cerebellar tissue. A In situ3 q 11
hybridization was performed with an antisense RNA from a transmembrane cDNA of type I IP receptor on tissue sections from a3
34-day-old rat. This figure is a bright field image of tissue that was briefly stained with Nissl, and shows intense labeling of odontoblasts.
 .B Odontoblast layer and dental pulp of incisor tooth from 34-day-old rat in which tissue was separated from the calcified dentin layer.
 .C Coronal section of adult human cerebellar tissue that was hybridized with antisense RNA from a transmembrane IP receptor probe3
 .under identical conditions. Tissue was briefly stained with Nissl, and shows intense labeling of individual Purkinje cells. D In situ
hybridization was performed with sense RNA from the same transmembrane cDNA of type I IP receptor on tissue sections from a3
 .34-day-old rat. Note absence of signal above odontoblast layer. E Immunolocalization of type I IP receptor in incisor tooth from rat.3
 .Bright field image shows intense staining of odontoblasts. F Immunolocalization of type III IP receptor in incisor tooth from rat to3
 .show intense staining of odontoblasts. G Immunolocalization of Ga rGa in incisor tooth from a 10-day-old rat that shows intenseq 11
 .staining of odontoblasts, and arterioles. H Preincubation of Ga rGa antibody with its cognate peptide. Specific binding ofq 11
Ga rGa antibody to rat protein was eliminated by preincubation of antibody with peptide prior to incubation with tissue sections. A,q 11
arterioles; D, dentin; DP, dental pulp; ML, molecular layer; GL, granular layer; P, Purkinje cell; O, odontoblast; and V, blood vessel.
Scale bar equals 50 mm for A–E, and 100 mm for F–H.
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3.2. In situ hybridization studies of rodent incisor
tissue
In situ hybridization with the transmembrane probe
pUP3 was carried out to determine the cellular local-
ization and relative expression of IP receptors in3
 .incisor tissue Fig. 2A–D . In rat maxillary incisors,
a uniformly dense hybridization signal surrounded
the entire perimeter of dental pulp, and this signal
labeled odontoblast cells. In contrast, dental pulp
exhibited very low labeling with this IP receptor3
 .probe Fig. 2A and 2B . These results indicate that
the vast majority of odontoblasts express IP recep-3
tors, and that this receptor is differentially expressed
in two major cell types of rodent incisor teeth. With
human cerebellar tissue, a high density of silver
grains was observed above individual Purkinje cells
 .with this probe Fig. 2C . Finally, no corresponding
signal was observed with sense control transcripts in
 .either odontoblast Fig. 2D or cerebellar control
tissue.
3.3. Immunolocalization of types I and III IP recep-3
tors and Ga rGa in rat incisor tissueq 11
Fig. 2E–H shows the results of immunolocaliza-
tion of IP receptor and Ga rGa protein subunits.3 q 11
The odontoblast layer of rat incisor teeth stained
intensely with antibodies that recognized type I IP3
 .receptor see Fig. 2E . In contrast, dental pulp showed
considerably lower labeling with this antibody. These
results indicated that type I IP receptor protein was3
localized to odontoblast membranes. Odontoblasts
showed a diffuse staining pattern with type I receptor
antibody that was consistent with a cytoplasmic
membrane localization. Similarly, subtype-specific
antibodies to type III IP receptor also stained the3
odontoblast layer of rat incisor teeth with a diffuse
 .staining pattern Fig. 2F . A considerably lower stain-
ing intensity was detected in dental pulp than in
odontoblasts. These results indicated that type III IP3
receptor proteins were also localized to odontoblast
membranes of rat incisor teeth. This immunocyto-
chemical study supported both the Northern blot and
in situ hybridization analyses of IP receptor expres-3
sion in odontoblasts, and suggested that the trans-
membrane IP receptor probe pUP3 hybridized to3
mRNAs of both type I and type III IP receptors.3
Antibodies that recognized a regulatory G-protein
of the IP signal transduction cascade were also3
localized to dental tissue. As shown in Fig. 2G,
antibodies that recognized Ga rGa densely stainedq 11
the odontoblast layer of rat incisors, and suggested
that this protein was localized to odontoblast cells. In
contrast, the dental pulp showed low staining inten-
sity with this antibody. However, antibodies against
Ga rGa densely stained the walls of arterioles inq 11
 .the dental pulp Fig. 2G . These arterioles are com-
posed of vascular smooth muscle cells, a cell popula-
 .tion known to be active in phosphatidylinositol PI
w xturnover 30 . Finally, Fig. 2H shows staining after
preabsorption and precipitation of Ga rGa anti-q 11
body with its cognate peptide. Essentially no
immunoreactivity was observed within odontoblasts
or arterioles after preabsorption of primary antibody.
4. Discussion
4.1. IP receptor expression in incisor teeth3
This report is the first to identify and characterize
IP receptorrchannels in odontoblasts. By three sepa-3
rate approaches, we have shown that IP receptors are3
highly expressed in odontoblasts of rat incisor teeth.
Our results also suggest that both type I and type III
IP receptors are expressed in odontoblast cells. Co-3
expression of multiple IP receptor subtypes within3
cells may be a universal characteristic of the IP3
w xsignaling pathway 12 , and implies that a population
of IP receptors may exist as heterotetramers in odon-3
toblasts. Since IP receptor subtypes differ in their3
affinities for ligand, heterotetrameric channels could
display a graduated range of ligand sensitivities for
activation and regulation of calcium channel activity
w x11 . These immunocytochemical studies with incisor
teeth further suggested that the majority of IP recep-3
torrchannels were localized to cytoplasmic mem-
branes of odontoblasts, and suggested an ER location.
This location is consistent with both the high expres-
sion of IP receptors in odontoblast membranes, and3
with the extensive network of ER membranes within
w xthese secretory cells 21 . Since odontoblasts are also
rich in secretory vesicles, a population of IP recep-3
tors could be localized to membranes of secretory
vesicles. In other secretory cells, localization of IP3
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w xreceptors to vesicle membranes is controversial 31 ,
but our results cannot exclude this possibility.
4.2. Possible roles for IP receptors in incisor teeth3
IP receptorrchannels may have specific functions3
in odontoblasts. For example, rat incisor teeth grow
continuously, and this receptor may be involved in
growth and differentiation of odontoblast cells. A
similar role for IP has been proposed in neural tissue3
w x27 . Another possible role for IP receptors in odon-3
toblasts involves the regulation of calcium release for
dentin formation. Odontoblasts are critical for miner-
alization of dentin since these secretory cells actively
transport calcium to the site of dentin formation
w x20,21 . The majority of odontoblast calcium is bound
to proteins such as phosphophoryn, a high capacity
binding protein that binds calcium at relatively high
w xaffinities 32,33 . If IP receptorrchannels are local-3
ized to ER membranes of odontoblasts, IP3
receptorrchannels could serve as one mechanism to
regulate calcium release from internal membrane
stores. This released calcium could then bind to
carrier proteins such as phosphophoryn for transport
to the sites of dentin formation.
Alpha subunits of the pertussis toxin-insensitive
G class of G-proteins were also localized to odonto-q
blasts. This class of G-proteins is coupled to a phos-
 . w xphoinositide-specific phospolipase C PI-PLC 34 ,
and ligand-mediated stimulation of PI-PLC by
w xGa rGa activation has been reported 35–37 .q 11
Our results suggest that some PI turnover in odonto-
blasts may be regulated by receptor-mediated activa-
tion of specific G-proteins that couple to PI-PLC.
This PLC could then catalyze the formation of IP for3
gating calcium flux through IP receptorrchannels in3
odontoblasts. Finally, the specialized function of
odontoblasts in dentin formation suggests that this
cell system may be a good model for identifying a
specific role for IP receptors and calcium release in3
the regulation of secretory activity.
In summary, this work is the first characterization
of IP receptorrchannel expression and Ga rGa3 q 11
expression in odontoblasts. The expression of IP3
receptors in these specialized cells is one of the
highest observed outside the nervous system, and this
receptor may have an important role in dentin
metabolism.
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